Ph I Dasatinib + Erlotinib in Recurrent MG
Clinical trial NCT00609999 · COMPLETED
Trial details
- NCT number
- NCT00609999
- Sponsor
- Duke University
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-01-01
- Primary completion
- 2010-07-01
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.